{
    "clinical_study": {
        "@rank": "19863", 
        "arm_group": [
            {
                "arm_group_label": "Resveratrol 5mg", 
                "arm_group_type": "Experimental", 
                "description": "Twice a day given purple rice with 5mg of resveratrol."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Plain Purple rice given twice a day"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a pilot study to demonstrate the effect of purple rice on post-prandial glucose and\n      insulin. The purple color is due, like red wine grapes, mainly to the anthocyanins.  The\n      safety and tolerability of purple rice is similar to white or brown rice, but contains the\n      purple elements common to other foods like grapes."
        }, 
        "brief_title": "Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetic", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "detailed_description": {
            "textblock": "This is a study that will have 1 screening visit and 9 study visits. Subjects will come to\n      the screening visit for blood chemistry, health questionnaire and speak to the coordinator.\n      Each subject passing inclusion/exclusion will go on to eat purple rice for 4 weeks and brown\n      rice for 4 weeks. The 4-week feeding periods will be balanced and assigned randomly.  The\n      subjects will report to the metabolic kitchen to pick up their supply of 14 frozen rice\n      dishes each week in a container and return the empty containers as a measure of compliance.\n      At the end of each 4-week feeding period, subjects will come to the inpatient unit fasting\n      from 9pm the prior night except for water. Subjects will have an intravenous line placed and\n      fasting blood will be drawn for chemistry. Subjects will then be given glucose to drink and\n      blood will be drawn from then IV line for glucose and insulin at time listed in the consent."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Generally healthy male or female with a fasting glucose between 100 mg/mL and 126\n             mg/dL or with type 2 diabetes controlled on diet without diabetes medications.\n\n          -  Eighteen years of age or older.\n\n          -  Hemoglobin A1c(HgbA1c) less than 7%.\n\n        Exclusion Criteria:\n\n          -  Pregnant or nursing.\n\n          -  Taking a medication for diabetes (e.g. Metformin), a medication known to affect blood\n             sugar (e.g. glucocorticoids), an anti-inflammatory medication (e.g. aspiring) or\n             triglycerides (e.g. fibrates).\n\n          -  Any chronic medication that has not had a stable dose for 1 month or longer."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720511", 
            "org_study_id": "PBRC12002"
        }, 
        "intervention": {
            "arm_group_label": "Resveratrol 5mg", 
            "description": "Incorporate one cup of purple or brown rice with resveratrol into dishes to be consumed at lunch and dinner each day for 4 weeks (equivalent of 4 ounces of uncooked rice/day).", 
            "intervention_name": "Resveratrol 5mg", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Resveratrol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "contact": {
                "email": "recruiters@pbrc.edu", 
                "last_name": "Grace Bella", 
                "phone": "225-763-3000"
            }, 
            "facility": {
                "address": {
                    "city": "Baton Rouge", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70808"
                }, 
                "name": "Pennington Biomedical Research Center"
            }, 
            "investigator": [
                {
                    "last_name": "Frank L. Greenway, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "John Finley, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation.", 
        "overall_contact": {
            "email": "doctors@pbrc.edu", 
            "last_name": "Frank L. Greenway, MD", 
            "phone": "225-763-3000"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will have an Intravenous line placed and fasting blood will be drawn. Subjects will then be given glucose to drink and blood will be drawn from an IV line for glucose and insulin.", 
            "measure": "Glucose Tolerance", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720511"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pennington Biomedical Research Center", 
            "investigator_full_name": "Frank Greenway", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Subjects will have an Intravenous line placed and fasting blood will be drawn for a chemistry-15 panel and High-sensitivity C-reaction Protein. Subjects will then be given 75 grams of glucose to drink and blood will be drawn from an IV line for glucose and insulin.", 
                "measure": "Serum Lipids", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "description": "A high-sensitivity CRP (hs-CRP), that can be done in the lab using a blood test.", 
                "measure": "Inflammation measured by highly sensitive C-reative protein test", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }
        ], 
        "source": "Pennington Biomedical Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pennington Biomedical Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}